拉丁美洲癌癥情況分析報(bào)告-外文版培訓(xùn)課件2024.7temu

POLITICS

&

SOCIETYCancerinLatinAmericaCHAPTER

01OverviewPercentageofadultsworldwidewhostatedselectissueswerethebiggesthealthproblemsfacingpeopleintheircountryin2023Leadinghealthproblemsworldwide2023Percentageofrespondents0%5%10%15%20%25%30%35%40%45%50%Mentalhealth44%CancerStress40%30%Obesity25%Drugabuse22%Diabetes18%17%AlcoholabuseHeartdisease15%15%Coronavirus/COVID-19Smoking12%Dementia8%Sexuallytransmitteddiseases(STD)HospitalsuperbugsOther4%3%2%4Description:Asurveyofpeoplefrom31differentcountriesaroundtheworldfoundthatmentalhealthwasthebiggesthealthproblemrespondentssaidwasfacingtheircountryin2023.Otherhealthproblemsreportedbyrespondentsincludedcancer,stress,andobesity.ReadmoreNote(s):Worldwide;July21toAugust4,2023;23,274respondents;16-74years;31countriesSource(s):IpsosPredictednumberofnewcancercasesworldwidefrom2022to2050Forecastednumberofnewcasesofcancerworldwidefrom2022to205040,000,00035,281,05635,000,00030,000,00025,000,00020,000,00015,000,00010,000,0005,000,000032,644,56229,885,20627,016,82324,112,62721,325,24519,976,49920222025203020352040204520505Description:In2022,therewerearound20millionnewcasesofcancerworldwide.Itispredictedthatthisnumberwillincreasetoaround35.3millionincidentcasesintheyear2050.Thisstatisticshowsthepredictednumberofnewcancercasesworldwidefrom2022to2050.ReadmoreNote(s):Worldwide;2022;allagesSource(s):InternationalAgencyforResearchonCancer;WHONumberofprevalentcancercasesworldwidein2022,bytypeofcancer*(per100,000population)12-monthprevalenceratesofcancerworldwidein2022,bycancertypePrevalentcancercasesper100,000population0510152025303540455055BreastProstate47.930.5Colorectum18.7Trachea,bronchusandlungCervixuteri16.211.9Corpusuteri9Thyroid8.3StomachBladder6.96.2Ovary6.15.9LiverandintrahepaticbileductsNon-HodgkinlymphomaLeukaemia5.34.56Description:Breastcancerwasthemostprevalentcancertypein2022witharound48womenlivingwiththistypeofcancerper100,000population.The12-monthprevalencerateforprostatecancerasofthistimewas30.5per100,000population.Thisstatisticshowsthenumberofprevalentcancercasesworldwidein2022,bytypeofcancer.ReadmoreNote(s):Worldwide;2022;allagesSource(s):InternationalAgencyforResearchonCancer;WHORateofcancerdeathsworldwidein2022,bytypeofcancer(per100,000population)Cancerdeathrateworldwidebytypeofcancerin2022Rateofdeathper100,000population024681012141618Trachea,bronchusandlungBreast16.812.7Colorectum8.1LiverandintrahepaticbileductsProstate7.47.37.1CervixuteriStomach6.1Oesophagus4.34.2PancreasOvary4Leukaemia3.1Brain,centralnervoussystemNon-Hodgkinlymphoma2.62.47Description:Lungcancerhadthehighestrateofdeathamongallcancertypesworldwidein2022.Inthatyear,therewerearound17deathsfromtrachea,bronchusandlungcancerper100,000population.Thedeathrateforallcancerswas91.1per100,000population.Thisstatisticshowstherateofcancerdeathsworldwidein2022,bytypeofcancer.ReadmoreNote(s):Worldwide;allagesSource(s):InternationalAgencyforResearchonCancer;WHODistributionofnewcancercasesworldwidein2022,byregionPercentageofnewcancercasesworldwidebyregion2022Africa5.9%Oceania1.3%LatinAmerica&theCaribbean7.8%NorthAmerica14.0%Asia49.2%Europe22.4%8Description:Forbothsexesofallages,thetotalnumberofnewcancercasesworldwidewasestimatedtobeapproximately19.98millionin2022.Around49percentofthesenewcancercaseswereinAsia.Thisstatisticdepictsthedistributionofnewcancercasesworldwidein2022,sortedbyregion.ReadmoreNote(s):Worldwide;allagesSource(s):InternationalAgencyforResearchonCancer;WHODistributionofcancerdeathsworldwidein2022,byregionPercentageofcancerdeathsworldwidebyregion2022NorthAmerica7.2%LatinAmerica&theCaribbeanOceania0.76%7.7%Africa7.8%Asia56.1%Europe20.4%9Description:Forbothsexesofallages,thetotalnumberofcancerdeathswasestimatedtobeapproximately9.74millionin2022.AroundonefifthofcancerdeathsthatyearoccurredinEurope.Thisstatisticdepictsthedistributionofcancerdeathsworldwidein2022,sortedbyregion.ReadmoreNote(s):Worldwide;allagesSource(s):InternationalAgencyforResearchonCancer;WHOCHAPTER

02RiskfactorsPrevalenceofdailysmokinginLatinAmericaandtheCaribbeanasof2021,bycountryPrevalenceofdailysmokingLatinAmerica&theCaribbean2021Prevalenceofdailysmoking15%

20%0%5%10%25%30%35%40%ChileUruguayArgentinaCuba34.61%24.52%24.17%22.84%SurinameTrinidadandTobagoMexico19.68%17.84%17.05%15.57%ParaguayNicaraguaVenezuelaPeru15.24%14.91%14.67%HondurasEcuador14.25%14.04%11Description:Asof2021,ChilewasthecountrywiththehighestprevalenceofdailysmokinginLatinAmericaandtheCaribbean.Asofthatyear,itwasestimatedthatover34percentofthepopulationaged15yearsandoldersmokedtobaccodaily.Meanwhile,thecountrywiththelowestprevalenceintheregionwasHaiti,with6.14percentofthepopulationwithinthatcategoryconsidereddailysmokers.ReadmoreNote(s):LAC;2021;15yearsandolderSource(s):IHME;OWIDForecastprevalenceofobesityamongadultsinLatinAmericaandtheCaribbeanin2035,bycountryForecastprevalenceofobesityinLatinAmerica&theCaribbean2035,bycountryForecastprevalence20%0%10%30%40%50%60%DominicanRepublic51%51%HaitiCostaRicaBahamas50%49%MexicoElSalvadorSaintVincentandtheGrenadines47%46%46%JamaicaSurinameArgentinaChileCubaHoduras44%44%43%43%42%42%12Description:By2035,theprevalenceofobesityintheDominicanRepublicandHaitiisforecasttobethehighestinLatinAmericaandtheCaribbean,witha51percentofitsadultpopulationexpectedtosufferfromthiscondition.TheseCaribbeannationsarefollowedbyCostaRicaandtheBahamas,estimatedtohaveanobesityprevalenceof50and49percent,respectively.ReadmoreNote(s):LACSource(s):RTIInternational;WorldObesityFederationAveragepercapitaconsumptionvolumeofalcoholicbeveragesinLatinAmericaandtheCaribbeanfrom2019to2028,bysegment(inliters)LatinAmerica&Caribbean:alcoholicdrinksconsumptionpercapita2019-2028,bytypeAlcoholicDrinksBeerSpiritsWineCider,Perry&RiceWineHardSeltzer706050403020100-10201920202021202220232024202520262027202813Description:Significantfluctuationsareestimatedforallsegmentsovertheforecastperiodfortheindicator'VolumeperCapita,Combined'.Consideringthesixdifferenttypespresentedinthisstatistics,'AlcoholicDrinks'leadstherankingwith56.5litresindicator'VolumeperCapita,Combined'.Contrastingly,'HardSeltzer'isrankedlast,with0.3litres.Theirdifference,comparedtotheAlcoholicDrinks,liesat56.2litres.ReadmoreNote(s):2019to2028;Athomemarket.At-homemarketdatacoversretailsalesviasuper-andhypermarkets,eCommerce,conveniencestores,andsimilarsaleschannels.Source(s):HealthydietcostsinLatinAmericaandtheCaribbeanfrom2017to2022(

inU.S.dollarsperpersonperday)LatinAmericaandtheCaribbean:healthydietcosts2017-20225.04.54.564.083.884.03.53.02.52.01.51.00.50.03.783.693.6220172018201920202021202214Description:InLatinAmericaandtheCaribbean,thecostofahealthydietreachedover4.5dollarsin2022.Thisrepresentsanincreaseofalmost12percentcomparedtothepreviousyear.

ReadmoreNote(s):LAC;2017to2022;*=purchasingpowerparity.Numbershavebeenroundedoffforclarity.ReadmoreSource(s):FAO;IFAD;UNICEF;WHO;WorldFoodProgrammeShareofgirlsaged9to14yearsoldvaccinatedagainstthehumanpapillomavirus(HPV)inselectedLatinAmericanandCaribbeancountriesin2021HPVvaccinationcoverageinLatinAmerica&theCaribbean2021,bycountryCoveragerate0%10%20%30%40%50%60%70%80%Brazil67%Chile57%PeruArgentinaHonduras53%53%53%Panama44%Bolivia36%BarbadosUruguayParaguay28%17%17%15%GuatemalaSaintVincentandtheGrenadinesColombia12%11%15Description:In2021,Brazilexhibitedthehighestcoveragerateofthehumanpapillomavirus(HPV)vaccineamongselectedcountriesinLatinAmericaandtheCaribbean,witharound67percentofgirlsbetween9and14yearsoldimmunizedagainstthevirus.Chilefollowed,withanHPVvaccinationcoveragerateofroughly57percentthatyear.Incontrast,onlyonepercentofteenagegirlsinMexicohadreceivedtherecommendeddosesoftheHPVvaccine.

ReadmoreNote(s):LAC;2021;consideringpercentageofgirlsaged9to14yearsoldthatreceivedtherecommendeddosesofHPVvaccineSource(s):WHOAveragePM2.5concentrationinselectedcitiesinLatinAmericain2023(inmicrogramspercubicmeterofair)MostpollutedcitiesbasedonPM2.5concentrationinLatinAmerica2023PM2.5concentrationinμg/m310

150520253035Coyhaique(Chile)Nacimiento(Chile)33.232.431.8Pachacámac(Peru)PadredelasCasas(Chile)Xonacatlán(Mexico)29.429.2TolucadeLerdo(Mexico)Carabayllo(Peru)28.32827.427.4Victoria(Chile)PuentePiedra(Peru)Guadalajara(Mexico)SanMiguelTotocuitlapilco(Mexico)AtotonilcodeTula(Mexico)MexicoCity(Mexico)25.825.725.122.316Description:Coyhaique–aChileancitylocatedtotheeastoftheAndesmountainrange–wasthemostpollutedcityinLatinAmericain2023,basedonfineairparticulatematterconcentration(PM2.5).Thatyear,thecityreportedanaveragePM2.5concentrationof33.2microgramspercubicmeter.ThiswasfollowedbyNacimiento,alsolocatedinChile,withanestimatedPM2.5concentrationofaround32.4μg/m3.ReadmoreNote(s):2023Source(s):IQAirCHAPTER

03IncidenceCancerincidencerateinLatinAmericaandtheCaribbeanin2022,bycancertype(per100,000population)CancerincidencerateinLatinAmerica&theCaribbean2022,bytypeNewcasesper100,000population20

3001040506070ProstateBreast57.551.9ColorectumCervixuteriLung16.815.212.2StomachThyroid8.58.3CorpusuteriOvaryLeukaemiaNon-HodgkinlymphomaLiver85.75.65.44.94.6Pancreas18Description:In2022,thecancertypewiththehighestage-standardizedincidencerateinLatinAmericaandtheCaribbeanwasprostatecancerwith57.5newcasesper100,000population.Itwasfollowedbybreastcancer,withanincidencerateofnearly52peopleper100,000population.Thatyear,prostatecancerwasthetypeofcancerwiththe?highestmortalityrateintheregion.ReadmoreNote(s):LAC;2022;age-standardizedrate;includesbothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerCancerincidencerateinLatinAmericaandtheCaribbeanin2022,bygender(per100,000population)CancerincidencerateinLatinAmerica&theCaribbean2022,bygenderNewcasesper100,000populationMale

Female150050100200250300350UruguayArgentinaCubaBrazilJamaicaBarbadosParaguayPeruTrinidadandTobagoBahamasColombiaVenezuela19Description:In2022,Uruguayhadthehighestage-standardizedcancerincidencerateamongmenandwomeninLatinAmericaandtheCaribbean,with322.3and253.2newcasesper100,000population,amongmenandwomen,respectively.Thatyear,prostatecancerwasthecancertypewiththehighestprevalencerateinLatinAmerica.ReadmoreNote(s):LAC;2022;age-standardizedrate;includesallcancers,bothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerNumberofnewcasesofcancerinLatinAmericaandtheCaribbeanin2022,bygenderCancerincidenceinLatinAmerica&theCaribbeanin2022,bygenderNumberofnewcancercasesMales

Females150,000050,000100,000200,000250,000300,000350,000319,711307,482BrazilMexicoArgentinaColombiaPeru95,954111,20065,04068,38056,22461,39633,72439,10331,374VenezuelaChile31,57332,80027,07626,892CubaEcuadorGuatemalaBoliviaDominicanRepublic22,79613,89016,9987,78310,0187,6929,88710,7359,43620Description:Brazilhadthehighestnumberofnewcancercasesin2022forbothwomenandmeninLatinAmericaandtheCaribbean,with307,482and319,711newcases,respectively,reachingatotalofoverhalfamillioncases.MexicoandArgentinafollowed,with207,154and133,420totalnewcases,respectively.Thatyear,thecountrywiththehighest?incidencerateofcancerintheregionwasUruguay.ReadmoreNote(s):LAC;2022Source(s):InternationalAgencyforResearchonCancerNumberofnewcancercasesinBrazilfrom2010to2023(in1,000s)IncidenceofcancerinBrazil2010-2023800704.08700625.37596.07582.59576.586005004003002001000518.51489.27201020122014201620182020202321Description:Duringtheperiodanalyzed,thenumberofnewcancercasesinBrazilsawanoverallincreasingtrend,goingfromaround489,000in2010toapproximately704,000casesin2023.Thehighestvaluewasobservedduringthelastyeardepicted.In2022,the?mostcommontypeofcaneramongnewlydiagnosedpatientsinthecountrywasprostatecancer.ReadmoreNote(s):Brazil;2010to2023Source(s):BrazilianNationalCancerInstituteForecastofnewcancercasesinMexicofrom2022to2050(in1,000s)CancerincidenceinMexico2022-2050450392.8840035030025020015010050359.57324.66289.18254.69222.47207.150202220252030203520402045205022Description:TheestimatednumberofnewcancercasesinMexicoisforecasttosteadilyincreaseinthecomingyears.Theincidencerateofcancerinthecountryisexpectedtoreachnearly393,000newcasesin2050.Thisfigureamountedto207,000casesin2022.Inthatyear,breastcancerwasthemostcommontypeofcanceramongnewlydiagnosedpatientsinthecountry.ReadmoreNote(s):Mexico;2022Source(s):InternationalAgencyforResearchonCancerNumberofnewcancercasesattendedinthegeneralhealthsocialsecuritysysteminColombiafrom2016to2022IncidenceofcancerinColombia2016-202250,00045,00046,87042,89340,00035,00030,00025,00020,00015,00010,0005,000037,63031,238201620182020202223Description:ThenumberofnewcancercasesregisteredinthegeneralhealthsocialsecuritysysteminColombiasawanoverallincreasingtrendduringtheperiodanalyzed,goingfromaround31,000casesin2015tocloseto47,000in2022.Duringthelastyeardepicted,theprevalencerateofcancerwithinthegeneralhealthsocialsecuritysysteminColombiaamountedto858.23casesper100,000population.ReadmoreNote(s):Colombia;2015to2022Source(s):CuentadeAltoCostoCHAPTER

04PrevalenceCancerprevalencerateinLatinAmericaandtheCaribbeanin2022,bycancertype(per100,000population)CancerprevalencerateinLatinAmerica2022,bytypeNumberofcasesper100,000population100050150200250BreastProstate213.1175.8ColorectumCervixuteriCorpusuteriThyroid61.358.736.333.2OvaryLung20.520.420.3Non-HodgkinlymphomaLeukaemiaTestis18.316.4KidneyStomach16.115.925Description:ThecancertypewiththehighestprevalencerateinLatinAmericaandtheCaribbeanin2022wasbreastcancer,with220.5casesper100,000population.Thiswasfollowedbybreastcancerandprostatecancer,withprevalenceratesof213.1and175.8casesper100,000population,respectively.Thatyear,breastandprostatecancerwerealsothetwocancertypeswiththehighestmortalityratesintheregion.

ReadmoreNote(s):LAC;2022;age-standardizedrate;includesbothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerCancerprevalencerateinLatinAmericaandtheCaribbeanin2022,bygender(per100,000population)CancerprevalencerateinLatinAmerica&theCaribbean2022,bygenderNumberofcasesper100,000populationMale

Female60002004008001,0001,2001,400UruguayBarbadosCubaArgentinaTrinidadandTobagoChileBrazilBahamasCostaRicaJamaicaColombiaPeru26Description:Asof2022,thecountrywiththehighestage-standardizedcancerprevalencerateamongbothmenandwomeninLatinAmericaandtheCaribbeanwasUruguay,with1331.5and1301.6casesper100,000populationamongmenandwomen,respectively.Whileinsomecountries,suchasChileandCuba,menhadhighercancerprevalenceratesthanwomen,theoppositewastrueinmostLatinAmericanandCaribbeannations.Thatyear,womenhadthehighestcancermortalityratein[...]

ReadmoreNote(s):LAC;2022;age-standardizedrate;includesallcancers,bothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerPrevalenceofcancerinLatinAmericaandtheCaribbeanin2022,bygenderCancerprevalenceinLatinAmericaandtheCaribbean2022,bygenderNumberofcancercasesMalesFemales500,0000100,000200,000300,000400,000600,000700,000800,000900,0001,000,000771,444BrazilMexicoArgentinaColombiaPeru862,997248,340329,147180,039215,919133,132170,52479,256106,11471,568VenezuelaChileCubaEcuadorDominicanRepublicBolivia83,75592,08977,79363,67562,36232,48846,39025,40825,90516,33225,68322,509Uruguay23,50027Description:In2022,Brazilwasthecountrywheretheprevalenceofcancercaseswithinafive-yearperiodforbothmenandwomenwasthehighest,withover860,000casesamongwomenand771,000casesamongmen,respectively.Mexicofollowedinsecondplace,withaprevalenceofapproximately330,000casesforwomenand248,000casesformen.Thatyear,theLatinAmericancountrywiththehighestprevalenceratewasUruguay.

ReadmoreNote(s):LAC;2022Source(s):InternationalAgencyforResearchonCancerPrevalenceofcancerinBrazilin2022,byprevalenceperiod(in1,000s)CancerprevalenceinBrazil2022,byprevalenceperiodPrevalentcasesinthousands02004006008001,0001,2001,4001,6001,8001-year3-year5-year432.961,106.371,634.4428Description:In2022,theprevalenceofcancerwithinafive-yearperiodinBrazilamountedtoanestimated1.6millioncases.Whenconsideringathree-yearperiod,thisfigurereachedthe1.1millioncases.In2023,the?incidenceofcancercasesinthecountrysurpassedthe700,000.ReadmoreNote(s):Brazil;2022Source(s):InternationalAgencyforResearchonCancerPrevalenceofcancerinMexioin2022,byprevalenceperiod(in1,000s)CancerprevalenceinMexico2022,byprevalenceperiodPrevalentcasesinthousands01002003004005006007001-year3-year5-year148.28385.58577.4929Description:In2022,theprevalenceofcancerwithinafive-yearperiodinMexicoamountedtoanestimated577,000cases.Whenconsideringathree-yearperiod,thisfigurereachedthe386,000cases.Duringtheyearanalyzed,theincidenceofcancercasesinthecountrysurpassedthe200,000.ReadmoreNote(s):Mexico;2022Source(s):InternationalAgencyforResearchonCancerPrevalencerateofcancerattendedinthegeneralhealthsocialsecuritysysteminColombiafrom2015to2022(per100,000population)CancerprevalencerateinColombia2015-20221,000900858.23783.328007006005004003002001000670.14531533.5446.9393.6339.82015201620172018201920202021202230Description:TheprevalencerateofcancerattendedinthegeneralhealthsocialsecuritysysteminColombiaamountedtocloseto860casesper100,000populationin2022.Thisfiguresawanoverallincreaseduringtheperiodanalyzed.Duringthelastyeardepicted,themostcommontypeofcanceramongnewlydiagnosedpatientsinthecountrywasbreastcancer.ReadmoreNote(s):Colombia;2015to2022Source(s):CuentadeAltoCostoCHAPTER

05MortalityCancermortalityrateinLatinAmericaandtheCaribbeanin2022,bycancertype(per100,000population)CancermortalityrateinLatinAmerica&theCaribbean2022,bytypeNumberofdeathsper100,000population0246810121416Prostate13.9BreastLung13.210.4Colorectum8.2Cervixuteri7.7Stomach6.6LiverPancreas4.54.3Leukaemia3.7Ovary3.6Brain,centralnervoussystemNon-HodgkinlymphomaOesophagus2.92.32.232Description:Thecancertypewiththehighestage-standardizedmortalityrateinLatinAmericaandtheCaribbeanin2022wasprostatecancerwith13.9deathsper100,000population.Breastcancerrankedsecond,withamortalityrateof13.2peopleper100,000population.Inthatyear,breastcancerwasthecancertypewiththehighestprevalenceintheregion.ReadmoreNote(s):LAC;2022;age-standardizedrate;

includesbothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerCancermortalityrateinLatinAmericaandtheCaribbeanin2022,bygender(per100,000population)CancermortalityrateinLatinAmerica&theCaribbean2022,bygenderNumberofdeathsper100,000populationMales

Females800204060100120140160180JamaicaBarbadosBahamasUruguayBoliviaCubaTrinidadandTobagoArgentinaPeruDominicanRepublicHaitiHonduras33Description:In2022,thenationwiththehighestage-standardizedmortalityrateofallcancertypesamongwomeninLatinAmericaandtheCaribbeanwasJamaicawith110.6womenper100,000population.Inthecaseofmen,thecountrywiththehighestratewasBarbados,with124.9cancerdeathsper100,000men.Whilethecancerdeathratewashigherformenthanwomeninmostofthelistedcountries,theoppositewastrueinPeruandBolivia.Thatyear,bothwomenandmenhadthehighest[...]

ReadmoreNote(s):LAC;2022;age-standardizedrate;includesallcancers,bothsexes,andallagesSource(s):InternationalAgencyforResearchonCancerNumberofdeathsfromcancerinLatinAmericaandtheCaribbeanin2022,bygenderCancerdeathsinLatinAmerica&theCaribbean2022,bygenderNumberofcancer-relateddeathsMales

Females60,000

80,000020,00040,000100,000120,000140,000160,000146,702BrazilMexicoArgentinaColombiaPeru132,13346,41549,79536,58833,66327,81628,90316,79019,14416,346VenezuelaChile15,39116,89714,54315,854CubaEcuadorBoliviaGuatemalaDominicanRepublic11,8707,6588,5004,9586,0574,5445,8256,1765,56834Description:In2022,Brazilwasthecountrywherecancer-relateddeathsforbothmenandwomenwerethehighest,withover132,000casesamongwomenandnearly147,000casesamongmen,respectively.Mexicofollowedinsecondplace,with50,000casesforwomenand46,000casesformen.Inthatyear,thecountrywiththehighestmortalityrateinLatinAmericawasUruguay.ReadmoreNote(s):LAC;2022Source(s):InternationalAgencyforResearchonCancerCancermortalityrateinBrazilfrom2010to2022(per100,000inhabitants)CancermoratlityrateinBrazil2010-20229079.9979.3379.1479.2878.7578.8278.7978.3578.0878.128070605040302010075.5373.5673.23201020112012201320142015201620172018201920202021202235Description:ThemortalityrateofcancerinBrazilsawanoveralldecreaseduringtheperiodanalyzed,goingfromaround80deathsper100,000populationin2010toaround76deathsper100,000populationin2022.Duringthelastyeardepicted,thetypeofcancerrelatedtomostcancerdeathsinBrazilwaslungcancer.ReadmoreNote(s):Brazil;2010to2022Source(s):BrazilianNationalCancerInstitute;PAHOCancermortalityrateinMexicofrom2012to2022(per100,000inhabitants)CancermortalityinMexico2012-2022807070.6769.7169.8768.9268.0667.4366.7664.9863.6962.9162.0460504030201002012201320142015201620172018201920202021202236Description:CancermortalityinMexicoincreasedcontinuouslyfrom2012to2020.Atthebeginningoftheperiodanalyzed,62deathsper100,000peopleduetocancerwererecordedintheNorthAmericancountry,comparedto70deathsper100,000peoplein2020.Thisfiguredecreasedduringthefollowingtwoyears.ReadmoreNote(s):Mexico;2012to2022Source(s):INEGI;Varioussources(ConsejoNacionaldePoblación(CONAPO))CancermortalityrateinColombiafrom2013to2022(per100,000inhabitants)CancermortalityinColombia2013-2022120100999797.597.496.696.394.291.99086.4806040200201320142015201620172018201920202021202237Description:CancermortalityrateinColombiafluctuatedbetween86.4and99deathsper100,000peoplebetween2012and2022,reachingitshighestvaluein2019,anditslowestvalueatthebeginningoftheperiod.In2022,cancermortalityrateinthecountryamountedto96.6deathsper100,000people.ReadmoreNote(s):Colombia;2013to2022Source(s):DANE(Colombia)CHAPTER

06ResourcesNumberofhospitalsinselectedcountriesinLatinAmericaasofApril2022,bytypeNumberofhospitalsinLatinAmerica2022,bytypePrivatePublic8,0007,0006,0005,0004,0003,0002,0001,0000BrazilMexicoArgentinaColombiaPeruChile39Description:In2022,BrazilhadthehighestnumberofhospitalsinLatinAmerica,withmorethanseventhousand.Thatyear,around63percentofBrazilianhospitalswereprivate,while37percentwerepublichospitals.Similarly,Mexicanprivatehospitalsamountedto2,303institutions,whilepublichospitalstotaled1,352intheNorthAmericancountrythatyear.ReadmoreNote(s):LAC;2022Source(s):GlobalHealthIntelligence;estimatesShareofhospitalswithselectedtypesofbasichospitalequipmentinLatinAmericain2023HospitalswithbasicequipmentinLatinAmerica2023,bytypeShareofhospitalswithbasicequipment30%

40%

50%0%10%20%60%70%80%90%ECGmachinesUltrasoundmachinesX-raymachines83%71%68%Ventilators59%Infusionpumps57%PatientmonitoringsystemsAnesthesiamachines40%38%40Description:AsofJuly2023,theshareofhospitalswithECGmachinesinLatinAmericanwasestimatedat83percent.Thatyear,ultrasoundmachineswerefoundin71percentofhospitals,whilethesamefigureequaled68percentforx-raymachines.InMexico,theinstalledbaseofultrasoundmachinesamountedtonearlyfivethousandunitsthatyear.ReadmoreNote(s):LAC;2023Source(s):GlobalHealthIntelligenceShareofhospitalswithselectedtypesofspec